Treatment pathways 

One would think that patients should have the freedom to choose how they want to treat their conditions, it turns out it's not that straightforward.

Pharmaceutical products that are currently on the market are obvious treatments that are available but the less obvious are promising treatments that are currently in development. So how does one access such a treatment?

FDA has defined stem cells as drug products. Any stem cell product that is designed to treat or cure a condition, is defined as a drug or more precisely, a biologic– a drug that comes from living sources. In the United States there are three ways to gain access to stem cells, called "treatment pathways."